The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

Por Pang, Lisa Y, Argyle, Sally A, Kamida, Ayako, Morrison, Katherine O’Neill, Argyle, David J
Publicado em 2014

Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation

Por Pang, Lisa Y., Gatenby, Emma L., Kamida, Ayako, Whitelaw, Bruce A., Hupp, Ted R., Argyle, David J.
Publicado em 2014